Form 4 for DNLI Denali Therapeutics Inc.
Accepted 2026-08-13 17:01:59 ET · period of report 2026-08-11 · accession 0001724311-26-000013 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-13 17:01 | 2026-08-11 | DNLI | Schuth Alexander O. | COFO, Sec | S - Sale | $25.07 | -2,857 | 281.8K | -1% | -$71.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-11 | S | D | 2,857 | $25.07 | 281,763 | D | — | — | (F1) Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested RSUs. (F2) Includes 135,475 Unvested RSUs. (F3) Includes 1,792 shares acquired under the ESPP Purchase on June 1, 2026. |